Literature DB >> 10195215

Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems.

S Alagarsamy1, M J Marino, S T Rouse, R W Gereau, S F Heinemann, P J Conn.   

Abstract

The metabotropic glutamate receptor, mGluR5, has a critical role in induction of NMDA-receptor-dependent forms of synaptic plasticity and excitotoxicity. This is likely mediated by a reciprocal positive-feedback interaction between these two glutamate receptor subtypes in which activation of mGluR5 potentiates NMDA receptor currents and NMDA receptor activation potentiates mGluR5-mediated responses. We have investigated the mechanism by which NMDA receptor activation modulates mGluR5 function and find evidence that this response is mediated by activation of a protein phosphatase and a resultant dephosphorylation of protein kinase C phosphorylation sites on mGluR5. This form of neuromodulation may be important in a number of normal and pathological processes that involve activation of the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195215     DOI: 10.1038/6338

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  54 in total

Review 1.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

2.  NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin.

Authors:  Sudar Alagarsamy; Julie Saugstad; Lee Warren; Isabelle M Mansuy; Robert W Gereau; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2005       Impact factor: 5.250

3.  Metabotropic glutamate receptors in the trafficking of ionotropic glutamate and GABA(A) receptors at central synapses.

Authors:  Min-Yi Xiao; Bengt Gustafsson; Yin-Ping Niu
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 4.  A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.

Authors:  Giulia Ambrosi; Silvia Cerri; Fabio Blandini
Journal:  J Neural Transm (Vienna)       Date:  2014-01-01       Impact factor: 3.575

Review 5.  Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

Authors:  Andreas Reiner; Joshua Levitz
Journal:  Neuron       Date:  2018-06-27       Impact factor: 17.173

6.  Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Authors:  Anna Jiménez; Merce Bonastre; Esther Aguilar; Concepcio Marin
Journal:  Psychopharmacology (Berl)       Date:  2009-07-28       Impact factor: 4.530

Review 7.  The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

Authors:  Carolyn C Rudy; Holly C Hunsberger; Daniel S Weitzner; Miranda N Reed
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

8.  Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1-/y mouse model.

Authors:  Camilla J Lundbye; Anna Karina H Toft; Tue G Banke
Journal:  J Physiol       Date:  2018-09-19       Impact factor: 5.182

Review 9.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.

Authors:  P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  Trends Pharmacol Sci       Date:  2008-12-06       Impact factor: 14.819

Review 10.  Phosphorylation of group I metabotropic glutamate receptors (mGluR1/5) in vitro and in vivo.

Authors:  Li-Min Mao; Xian-Yu Liu; Guo-Chi Zhang; Xiang-Ping Chu; Eugene E Fibuch; Lucy S Wang; Zhenguo Liu; John Q Wang
Journal:  Neuropharmacology       Date:  2008-06-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.